Department of Dermatology, Queens Medical Centre, Derby Road, Nottingham NG7 2UH, UK.
Department of Dermatology, Queens Medical Centre, Derby Road, Nottingham NG7 2UH, UK.
J Plast Reconstr Aesthet Surg. 2014 Oct;67(10):1315-21. doi: 10.1016/j.bjps.2014.05.021. Epub 2014 May 23.
Dermatofibrosarcoma protuberans (DFSP) is a rare low-grade sarcoma that typically presents with local invasion but rarely metastasises. Surgical excision remains the first-line treatment for DFSP. There are no randomised controlled or prospective studies comparing wide local excision (WLE) with Mohs micrographic surgery (MMS), but available evidence from the retrospective studies and case series available has consistently shown higher recurrence rates for standard surgery and WLE than for MMS. Combined recurrence rates of data within the last 20 years for WLE have been reported at 7.3% compared with 1.1% for MMS. Our aim was to review the clinical details and recurrence rates of DFSP cases treated with frozen-section MMS in our centre between 1996 and February 2013. The relevant data were collected from the case notes. It involved 76 patients with nine of these patients lost to follow-up. In the remaining 67 (67/76) cases, the recurrence rate was 1.5% during the mean follow-up period of 50 months (2-132). This is comparable to recurrence rates for the MMS in the literature [20,21]. Our series is the largest series for frozen-section MMS reported to date. Based on these findings and the current literature evidence, we advocate MMS as the treatment of choice for DFSP in all locations.
隆突性皮肤纤维肉瘤(DFSP)是一种罕见的低度恶性肉瘤,通常表现为局部侵袭,但很少转移。手术切除仍然是 DFSP 的一线治疗方法。没有随机对照或前瞻性研究比较广泛局部切除(WLE)与 Mohs 显微外科手术(MMS),但现有回顾性研究和病例系列的证据一致表明,标准手术和 WLE 的复发率高于 MMS。在过去 20 年的数据中,WLE 的综合复发率为 7.3%,而 MMS 为 1.1%。我们的目的是回顾 1996 年至 2013 年 2 月期间在我们中心接受冷冻切片 MMS 治疗的 DFSP 病例的临床细节和复发率。相关数据从病历中收集。共涉及 76 例患者,其中 9 例失访。在其余 67 例(67/76)患者中,平均随访 50 个月(2-132 个月)期间的复发率为 1.5%。这与文献中 MMS 的复发率相当[20,21]。我们的系列是迄今为止报道的最大的冷冻切片 MMS 系列。基于这些发现和目前的文献证据,我们主张 MMS 作为所有部位 DFSP 的首选治疗方法。